← Open Payments lookup

NATALIE OLIVER: Open Payments

NPI 1164194692 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,335 in 103 payments from 10 companies in 2025. Trend: 2023 $1,536 · 2024 $2,267 · 2025 $5,335

Food & beverage: $2,352Consulting: $2,250Travel & lodging: $732
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC36$3,612
Madrigal Pharmaceuticals26$680
Gilead Sciences, Inc.13$445
ORPHALAN INC6$167
Ipsen Biopharmaceuticals, Inc7$151
ABBVIE INC.9$146
Novo Nordisk Inc3$58
Boehringer Ingelheim Pharmaceuticals, Inc.1$30
Mirum Pharmaceuticals, Inc.1$24
Fujifilm Healthcare Americas Corporation1$23

Products named: TRULANCE, REZDIFFRA, XIFAXAN, CUVRIOR, IQIRVO, MAVYRET, CREON, Wegovy.

Industry payments across TX — which companies pay providers there.